1. Home
  2. WDFC vs BEAM Comparison

WDFC vs BEAM Comparison

Compare WDFC & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WDFC
  • BEAM
  • Stock Information
  • Founded
  • WDFC 1953
  • BEAM 2017
  • Country
  • WDFC United States
  • BEAM United States
  • Employees
  • WDFC N/A
  • BEAM N/A
  • Industry
  • WDFC Major Chemicals
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WDFC Industrials
  • BEAM Health Care
  • Exchange
  • WDFC Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • WDFC 2.7B
  • BEAM 2.3B
  • IPO Year
  • WDFC N/A
  • BEAM 2020
  • Fundamental
  • Price
  • WDFC $197.37
  • BEAM $20.50
  • Analyst Decision
  • WDFC Strong Buy
  • BEAM Strong Buy
  • Analyst Count
  • WDFC 2
  • BEAM 11
  • Target Price
  • WDFC $311.00
  • BEAM $49.40
  • AVG Volume (30 Days)
  • WDFC 109.3K
  • BEAM 2.2M
  • Earning Date
  • WDFC 01-09-2026
  • BEAM 11-04-2025
  • Dividend Yield
  • WDFC 1.90%
  • BEAM N/A
  • EPS Growth
  • WDFC 30.92
  • BEAM N/A
  • EPS
  • WDFC 6.69
  • BEAM N/A
  • Revenue
  • WDFC $619,985,000.00
  • BEAM $55,701,000.00
  • Revenue This Year
  • WDFC $6.82
  • BEAM N/A
  • Revenue Next Year
  • WDFC $6.02
  • BEAM $19.01
  • P/E Ratio
  • WDFC $29.52
  • BEAM N/A
  • Revenue Growth
  • WDFC 4.98
  • BEAM N/A
  • 52 Week Low
  • WDFC $187.40
  • BEAM $13.53
  • 52 Week High
  • WDFC $289.10
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • WDFC 50.94
  • BEAM 35.30
  • Support Level
  • WDFC $192.49
  • BEAM $20.76
  • Resistance Level
  • WDFC $202.47
  • BEAM $22.72
  • Average True Range (ATR)
  • WDFC 4.10
  • BEAM 1.65
  • MACD
  • WDFC 0.11
  • BEAM -0.29
  • Stochastic Oscillator
  • WDFC 58.83
  • BEAM 6.05

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: